Oncología radioterápica

2019

1. Androgen Deprivation Therapy and Salvage Radiotherapy: Are We Missing Something?

   European Urology

2. Are there enough radiation oncologists to lead the new Spanish radiotherapy?

   Clinical and Translational Oncology, Vol. 21, Núm. 12, pp. 1663-1672

3. Cardiovascular disease and survival in non-small cell lung cancer: a multicenter prospective assessment

   Clinical and Translational Oncology, Vol. 21, Núm. 9, pp. 1220-1230

4. Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology

   Clinical and Translational Oncology, Vol. 21, Núm. 4, pp. 420-432

5. Impact of rectum and bladder anatomy in intrafractional prostate motion during hypofractionated radiation therapy

   Clinical and Translational Oncology, Vol. 21, Núm. 5, pp. 607-614

6. Late toxicity after single dose HDR prostate brachytherapy and EBRT for localized prostate cancer: Clinical and dosimetric predictors in a prospective cohort study

   Radiotherapy and Oncology, Vol. 135, pp. 13-18

7. Long-term Outcomes and Patterns of Failure Following Trimodality Treatment With Bladder Preservation for Invasive Bladder Cancer

   Urology, Vol. 124, pp. 183-190

8. Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy

   European Urology, Vol. 76, Núm. 6, pp. 732-739

9. Oligometastatic prostate cancer: The game is afoot

   Cancer Treatment Reviews, Vol. 73, pp. 84-90

10. Oral and maxillary metastases: Retrospective clinical analysis of 21 cases

    Revista Espanola de Cirugia Oral y Maxilofacial, Vol. 41, Núm. 3, pp. 99-108

11. Oral and maxillary metastases: retrospective clinical analysis of 21 cases

    Revista española de cirugía oral y maxilofacial: Publicación Oficial de la Sociedad Española de Cirugía Oral y Maxilofacial, Vol. 41, Núm. 3, pp. 99-108

12. Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18-F) choline PET-CT

    European Journal of Cancer Care, Vol. 28, Núm. 5

13. Patient-Reported Outcomes–Secondary Analysis of the SCORE-2 Trial Comparing 4 Gy × 5 to 3 Gy × 10 for Metastatic Epidural Spinal Cord Compression

    International Journal of Radiation Oncology Biology Physics, Vol. 105, Núm. 4, pp. 760-764

14. Predictors of Outcomes and a Scoring System for Estimating Survival in Patients Treated With Radiotherapy for Metastatic Spinal Cord Compression From Small-Cell Lung Cancer

    Clinical Lung Cancer, Vol. 20, Núm. 4, pp. 322-329

15. Radiotherapy for metastatic spinal cord compression with increased radiation doses (RAMSES-01): A prospective multicenter study

    BMC Cancer, Vol. 19, Núm. 1

16. Survival after biochemical failure in prostate cancer treated with radiotherapy: Spanish Registry of Prostate Cancer (RECAP) database outcomes

    Clinical and Translational Oncology, Vol. 21, Núm. 8, pp. 1044-1051

17. The single nucleotide variant rs2868371 associates with the risk of mortality in non-small cell lung cancer patients: A multicenter prospective validation

    Radiotherapy and Oncology, Vol. 136, pp. 29-36

18. author reply

    Urology